2013
DOI: 10.1097/adm.0b013e31828e1881
|View full text |Cite
|
Sign up to set email alerts
|

The Synthetic Cannabinoid Withdrawal Syndrome

Abstract: The acute withdrawal syndrome appears to be characterized mainly by anxiety and tachycardia in the absence of any neurological findings or electrolyte disturbances. We describe two patients with symptoms consistent with withdrawal presumably due to synthetic cannabinoid use. The most appropriate treatment for such patients remains unknown, however benzodiazepines are a reasonable first line approach and quetiapine may have some efficacy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
69
0
2

Year Published

2015
2015
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 98 publications
(72 citation statements)
references
References 11 publications
1
69
0
2
Order By: Relevance
“…I want to fight and get exhausted" (25-year-old male university graduate). Anxiety and tachycardia findings have been found in acute deprivation, while neurologic findings and electrolyte abnormalities have not been found (Nacca et al, 2013). One study (Hoyte et al, 2012) stated that symptoms of tachycardia, agitation, drowsiness/lethargy, confusion, and hallucination are seen the most.…”
Section: Theme 5: Participants' Experiences After Using Bonsai and Thmentioning
confidence: 99%
“…I want to fight and get exhausted" (25-year-old male university graduate). Anxiety and tachycardia findings have been found in acute deprivation, while neurologic findings and electrolyte abnormalities have not been found (Nacca et al, 2013). One study (Hoyte et al, 2012) stated that symptoms of tachycardia, agitation, drowsiness/lethargy, confusion, and hallucination are seen the most.…”
Section: Theme 5: Participants' Experiences After Using Bonsai and Thmentioning
confidence: 99%
“…Regarding tolerance, dependency and withdrawal symptoms, [90,91] 3 cases have been reported, in particular one concerning a 20-year-old man who rapidly increased his use of "Spice gold" to 3 g a day, who on days 4-7 of his hospitalisation presented signs of craving, with nightmares, sweating, trembling, headache, blood pressure at 180/90 mmHg and tachycardia (125 bpm).…”
Section: Synthetic Cannabinoidsmentioning
confidence: 99%
“…According to clinical case reports, withdrawal symptoms are similar to those seen in users of natural cannabis, but more serious. Some chronic users experience withdrawal symptoms when they reducing doses [37], and report anxiety, headache, limb cramps, chills, anorexia and intense drug cravings [38,39]. In some countries they currently represent an important group of patients who demand hospitalization for detoxification [40].…”
Section: Addictive Potentialmentioning
confidence: 99%